Daily Stock Analysis, FWP, Forward Pharma A/S, priceseries

Forward Pharma A/S. Daily Stock Analysis
Stock Information
Open
5.54
Close
5.16
High
5.62
Low
5.04
Previous Close
5.54
Daily Price Gain
-0.38
YTD High
8.77
YTD High Date
Feb 5, 2020
YTD Low
4.61
YTD Low Date
Mar 13, 2020
YTD Price Change
-1.48
YTD Gain
-22.30%
52 Week High
11.01
52 Week High Date
Dec 11, 2019
52 Week Low
4.61
52 Week Low Date
Mar 13, 2020
52 Week Price Change
-3.58
52 Week Gain
-40.96%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Jan 4. 2017
14.38
Feb 3. 2017
25.47
21 Trading Days
77.17%
Link
LONG
Jul 19. 2017
19.32
Aug 22. 2017
21.59
24 Trading Days
11.77%
Link
LONG
Aug 25. 2017
21.94
Sep 19. 2017
39.08
16 Trading Days
78.14%
Link
LONG
Jan 24. 2018
32.20
Jan 29. 2018
35.71
3 Trading Days
10.89%
Link
LONG
Nov 7. 2018
11.97
Nov 8. 2018
13.61
1 Trading Days
13.68%
Link
LONG
Feb 4. 2019
8.40
Feb 11. 2019
8.98
5 Trading Days
6.88%
Link
LONG
Mar 31. 2020
5.62
Apr 1. 2020
5.90
1 Trading Days
5.08%
Link
Company Information
Stock Symbol
FWP
Exchange
NasdaqGS
Company URL
http://www.forward-pharma.com
Company Phone
0114533444242
CEO
Claus Bo Svendsen
Headquarters
-
Business Address
OSTERGADE 24A, 1, COPENHAGEN, DENMARK 1100
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001604924
About

Forward Pharma is a biopharmaceutical company which engages in the research and production of medicinal treatment for multiple sclerosis and psoriasis. It focuses on the immunomodulatory compound dimethyl fumarate (DMF) and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.

Description

Forward Pharma A/S operates as a biopharmaceutical company. The company engages in developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. Forward Pharma A/S was founded in 2005 and is headquartered in Copenhagen, Denmark.